Cargando…

The molecular landscape of breast mucoepidermoid carcinoma

Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged in solid and cystic patterns. Despite their triple‐negative phenotype, breast MECs are generally considered low‐risk maligna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venetis, Konstantinos, Sajjadi, Elham, Ivanova, Mariia, Andaloro, Silvia, Pessina, Simona, Zanetti, Chiara, Ranghiero, Alberto, Citelli, Gabriele, Rossi, Chiara, Lucioni, Marco, Malapelle, Umberto, Pagni, Fabio, Barberis, Massimo, Guerini‐Rocco, Elena, Viale, Giuseppe, Fusco, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225218/ https://www.ncbi.nlm.nih.gov/pubmed/36916425 http://dx.doi.org/10.1002/cam4.5754

Ejemplares similares

Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
por: Porta, Francesca Maria, et al.
Publicado: (2023)

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
por: Fusco, Nicola, et al.
Publicado: (2020)

Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
por: Sajjadi, Elham, et al.
Publicado: (2023)

Improving HER2 testing reproducibility in HER2-low breast cancer
por: Sajjadi, Elham, et al.
Publicado: (2022)

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances
por: Ivanova, Mariia, et al.
Publicado: (2023)

Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
por: Ivanova, Mariia, et al.
Publicado: (2023)

Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
por: Sajjadi, Elham, et al.
Publicado: (2021)

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
por: Pagni, Fabio, et al.
Publicado: (2019)

Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
por: Sajjadi, Elham, et al.
Publicado: (2023)

Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients
por: Fumagalli, Caterina, et al.
Publicado: (2019)

HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
por: Ivanova, Mariia, et al.
Publicado: (2022)

Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
por: Sajjadi, Elham, et al.
Publicado: (2021)

Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
por: Venetis, Konstantinos, et al.
Publicado: (2021)

Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
por: Sajjadi, Elham, et al.
Publicado: (2022)

Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
por: Sajjadi, Elham, et al.
Publicado: (2020)

Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers
por: Venetis, Konstantinos, et al.
Publicado: (2020)

Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
por: Sajjadi, Elham, et al.
Publicado: (2022)

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
por: Pagni, Fabio, et al.
Publicado: (2020)

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
por: Venetis, Konstantinos, et al.
Publicado: (2021)

Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses
por: Fumagalli, Caterina, et al.
Publicado: (2020)

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization
por: Angerilli, Valentina, et al.
Publicado: (2021)

Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
por: Pescia, Carlo, et al.
Publicado: (2023)

Physical Exercise with or without Whole-Body Vibration in Breast Cancer Patients Suffering from Aromatase Inhibitor—Induced Musculoskeletal Symptoms: A Pilot Randomized Clinical Study
por: de Sire, Alessandro, et al.
Publicado: (2021)

Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
por: Blundo, Concetta, et al.
Publicado: (2021)

In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay
por: Fumagalli, Caterina, et al.
Publicado: (2022)

Standard operating procedures for biobank in oncology
por: Bonizzi, Giuseppina, et al.
Publicado: (2022)

PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
por: Lopez, Gianluca, et al.
Publicado: (2020)

Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study
por: Invernizzi, Marco, et al.
Publicado: (2020)

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
por: de Sire, Alessandro, et al.
Publicado: (2022)

Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review
por: Valenza, Carmine, et al.
Publicado: (2021)

Mucoepidermoid Carcinoma of the Tongue Base Mimicking an Ectopic Thyroid
por: Martellucci, Salvatore, et al.
Publicado: (2013)

FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint
por: Cappello, Filippo, et al.
Publicado: (2022)

Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs)
por: Piga, Isabella, et al.
Publicado: (2023)

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
por: Passaro, Antonio, et al.
Publicado: (2021)

The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience
por: Vigliar, Elena, et al.
Publicado: (2019)

Bronchial Mucoepidermoid Carcinoma
por: Gieraerts, Christopher, et al.
Publicado: (2016)

Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema
por: Invernizzi, Marco, et al.
Publicado: (2020)

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers
por: Fusco, Nicola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l7koe3lltjj3n36g2up8rtud0r